Details

Autor(en) / Beteiligte

• Moeller, Sebastian
• Wang, Ruihao
• Aydin, Merve
• Lam, Alexandra P.
• Sitter, Aileen
• Grüter, Jonas
• Philipsen, Alexandra
• Müller, Helge H.O.

Titel

Rapid titration protocol – Experiences with a dynamic novel titration regime for vagus nerve stimulation in a group of depressive patients

Ist Teil von

• Journal of clinical neuroscience, 2020-04, Vol.74, p.262-264

Ort / Verlag

Scotland: Elsevier Ltd

Erscheinungsjahr

2020

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• •Vagus nerve stimulation (VNS) is titrated slowly during ambulatory in-office visits.•We present a new rapid dosing regime for VNS in therapy-resistant depression (TRD).•The rapid dosing regime was well tolerated.•The rapid dosing regime may shorten the time to remission in TRD. Vagus nerve stimulation (VNS) is an established tool in the psychiatric armamentarium for patients with therapy-resistant depression (TRD) with response rates of approximately 60%. So far, VNS is titrated slowly during ambulatory in-office visits. Thus, antidepressive effects can be expected after approximately six months. We report our experiences with a rapid dosing regime (RDR) with titration start shortly after VNS-implantation. We retrospectively analysed data of six patients with TRD who received VNS. Stimulation parameters were evaluated with regard to clinical side effects, heart rates (HR) and blood pressures (BP). Depressive symptoms were measured by Montgomery-Asberg Depression Rating Scale (MADRS) one week before and three months after implantation of the VNS. All patients received first stimulation between one and four days after surgery. We elevated output current using 0.25 mA titration steps. We increased output current between one and four days after the last titration. All patients received 1.0 mA output current after eight to 14 days post-surgery. HR and BP remained stable in all patients. All side effects were mild and temporary. MADRS scores were significantly lower three months after VNS-implantation (24 ± 8) than one week before VNS-implantation (42 ± 4; p = 0.028). The therapeutic range of VNS-parameters for antidepressive effect was reached quicker without finding increased numbers of side effects. Consequently, by using RDR the antidepressive effect of VNS-therapy for patients with TRD could be reached earlier than using slow titration. Our presented RDR might be able to significantly shorten the “clinical effect gap” due to the neurobiological and titration-related latency.